News
-
-
PRESS RELEASE
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 10th interim report
Alzchem Group AG acquires 692 shares as part of a share buyback program. Detailed report available on company's website -
-
PRESS RELEASE
Alzchem Group AG successfully completes long-term succession planning for its Management Board: Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer with effect from 1 January 2026
Alzchem Group AG successfully completes long-term succession planning as Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer from January 1, 2026 -
-
PRESS RELEASE
Alzchem Group AG: Annual General Meeting approves 50% dividend increase to EUR 1.80 and re-election of Supervisory Board members
Alzchem Group AG approves 50% dividend increase to EUR 1.80 at Annual General Meeting and re-elects Supervisory Board members. Successful fiscal year 2024 showcased -
-
PRESS RELEASE
Alzchem Group AG continues earnings growth in the first quarter of 2025; projects to expand nitroguanidine capacity launched
Alzchem Group AG achieves earnings growth in Q1 2025 despite lower revenue, plans to expand nitroguanidine capacity. Positive outlook for sales and EBITDA growth in 2025 -
-
